Login
Sequoia unveils $950M in new early-stage funds as it strives to be ‘only as good as our next investment’
The legendary firm launched a $750 million early-stage fund targeting Series A startups and a $200 million seed fund.
The post Adaptam Therapeutics Funding Targets Tough Cancer Immunotherapy Challenge appeared first on StartupHub.ai.
Adaptam Therapeutics has raised €3 million in Adaptam Therapeutics funding to advance novel antibody-based cancer immunotherapies that disarm the tumor’s immune-suppressing defenses.
The post Adaptam Therapeutics Funding Targets Tough Cancer Immunotherapy Challenge appeared first on StartupHub.ai.
